AI assistant
PMV Pharmaceuticals, Inc. — Director's Dealing 2025
Jan 22, 2025
34350_dirs_2025-01-22_421053d1-be5b-40f7-8ea4-525b8ca8b5bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-12-03
Reporting Person: Mack David Henry (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-03 | Common Stock | M | 91750 | $0.53 | Acquired | 534210 | Direct |
| 2025-01-03 | Common Stock | M | 17709 | $0.53 | Acquired | 551919 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-03 | Employee Stock Option (right to buy) | $0.53 | M | 91750 | Disposed | 2025-05-11 | Common Stock (91750) | Direct |
| 2025-01-03 | Employee Stock Option (right to buy) | $0.53 | M | 17709 | Disposed | 2025-05-11 | Common Stock (17709) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 165307 | Indirect |
| Common Stock | 147915 | Indirect |
| Common Stock | 56978 | Indirect |
Footnotes
F1: The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F2: The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F3: The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
F4: The shares subject to the option are fully vested and immediately exercisable.